1. Home
  2. LGND vs WSBC Comparison

LGND vs WSBC Comparison

Compare LGND & WSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • WSBC
  • Stock Information
  • Founded
  • LGND 1987
  • WSBC 1870
  • Country
  • LGND United States
  • WSBC United States
  • Employees
  • LGND 68
  • WSBC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • WSBC Major Banks
  • Sector
  • LGND Health Care
  • WSBC Finance
  • Exchange
  • LGND Nasdaq
  • WSBC Nasdaq
  • Market Cap
  • LGND 3.2B
  • WSBC 2.8B
  • IPO Year
  • LGND 1992
  • WSBC N/A
  • Fundamental
  • Price
  • LGND $169.53
  • WSBC $32.09
  • Analyst Decision
  • LGND Strong Buy
  • WSBC Buy
  • Analyst Count
  • LGND 8
  • WSBC 5
  • Target Price
  • LGND $144.71
  • WSBC $39.20
  • AVG Volume (30 Days)
  • LGND 139.7K
  • WSBC 398.8K
  • Earning Date
  • LGND 08-05-2025
  • WSBC 10-22-2025
  • Dividend Yield
  • LGND N/A
  • WSBC 4.76%
  • EPS Growth
  • LGND N/A
  • WSBC N/A
  • EPS
  • LGND N/A
  • WSBC 1.65
  • Revenue
  • LGND $181,488,000.00
  • WSBC $690,805,000.00
  • Revenue This Year
  • LGND $18.41
  • WSBC $42.49
  • Revenue Next Year
  • LGND $18.87
  • WSBC $16.47
  • P/E Ratio
  • LGND N/A
  • WSBC $18.87
  • Revenue Growth
  • LGND 53.40
  • WSBC 22.64
  • 52 Week Low
  • LGND $81.74
  • WSBC $26.42
  • 52 Week High
  • LGND $129.90
  • WSBC $37.36
  • Technical
  • Relative Strength Index (RSI)
  • LGND 72.58
  • WSBC 53.12
  • Support Level
  • LGND $161.82
  • WSBC $30.61
  • Resistance Level
  • LGND $169.00
  • WSBC $33.05
  • Average True Range (ATR)
  • LGND 3.90
  • WSBC 0.65
  • MACD
  • LGND -0.81
  • WSBC -0.12
  • Stochastic Oscillator
  • LGND 98.73
  • WSBC 58.23

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About WSBC WesBanco Inc.

Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.

Share on Social Networks: